In this Application Highlight we discuss:
More about this Application Highlight
Recent clinical progress in immuno-oncology significantly improved clinical outcomes for many patients with hard-to-treat malignant tumors, leading to partial and complete remission and long-term survival in a fraction of patients.
However, a large number of patients do not respond to these treatments, creating an urgent need for novel strategies to enhance the efficacy of immunotherapies.
Download this App Note to see how IsoPlexis’ PSI helps you overcome these challenges.